STOCK TITAN

IMVT (NASDAQ: IMVT) holder plans sale of 5,800 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of IMVT common stock has filed a notice of proposed sale under Rule 144. The filing covers the planned sale of 5,800 common shares through Morgan Stanley Smith Barney LLC, with an approximate sale date of February 10, 2026 on the NASDAQ.

The shares to be sold were acquired as restricted stock from the issuer in January 2026 in two grants of 3,770 and 2,030 shares, both fully paid on their acquisition dates. The filing also lists recent sales of common shares by Michael Geffner over the prior three months, including multiple transactions in November 2025 and January 2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the IMVT Rule 144 filing disclose?

The filing discloses a planned sale of IMVT common shares under Rule 144. It details 5,800 common shares to be sold through Morgan Stanley Smith Barney LLC, the acquisition dates and form of restricted stock, and prior three-month sale activity by Michael Geffner.

How many IMVT shares are planned for sale under this Rule 144 notice?

The notice covers a planned sale of 5,800 IMVT common shares. These shares will be sold on the NASDAQ through Morgan Stanley Smith Barney LLC, as part of a Rule 144 transaction, following their acquisition as restricted stock in January 2026 from the issuer.

When are the IMVT shares expected to be sold under this Form 144?

The shares are expected to be sold around February 10, 2026. The filing lists this as the approximate sale date for the 5,800 IMVT common shares to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

How were the IMVT shares being sold under Rule 144 originally acquired?

The IMVT shares were acquired as restricted stock from the issuer in January 2026. One grant of 3,770 shares was acquired on January 17, 2026, and another 2,030 shares on January 2, 2026, with payment listed as not applicable, consistent with equity awards.

What prior IMVT share sales has Michael Geffner reported in the last three months?

Michael Geffner reported several IMVT common share sales in the last three months. Transactions include 103,897 shares on November 25, 2025, 50,000 shares on November 26, 2025, 1,406 shares on January 7, 2026, and 2,480 shares on January 21, 2026, with disclosed gross proceeds.

Through which broker will the IMVT Rule 144 shares be sold?

The shares will be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction is designated for execution on the NASDAQ exchange.
Immunovant Inc

NASDAQ:IMVT

IMVT Rankings

IMVT Latest News

IMVT Latest SEC Filings

IMVT Stock Data

5.37B
85.53M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
DURHAM